XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME        
Sales, net $ 12,505 $ 12,955 $ 37,891 $ 38,707
Cost of goods sold 5,146 4,769 14,951 14,838
Gross profit 7,359 8,186 22,940 23,869
Operating expense        
Selling, general and administrative 3,252 2,933 9,693 8,779
Research & development 138 112 414 370
Total operating expense 3,390 3,045 10,107 9,149
Operating income 3,969 5,141 12,833 14,720
Other income 812 198 2,239 348
Income before provision for income taxes 4,781 5,339 15,072 15,068
Provision for income taxes 846 1,059 2,723 3,150
Net income $ 3,935 $ 4,280 $ 12,349 $ 11,918
Earnings per common share (basic) $ 1.08 $ 1.18 $ 3.40 $ 3.27
Earnings per common share (diluted) $ 1.08 $ 1.18 $ 3.39 $ 3.26
Shares outstanding - basic 3,629 3,625 3,629 3,641
Shares outstanding - diluted 3,639 3,634 3,638 3,650
Other comprehensive income (loss)        
Foreign currency translation net of taxes of $0 in all periods $ (1,012) $ (2,572) $ 41 $ (5,377)
Total comprehensive income $ 2,923 $ 1,708 $ 12,390 $ 6,541